Financials

News Discussions Technicals Forecast Seasonals

Gross profit of Candel Therapeutics, Inc.

Annual data

2020

2021

2022

2023

TTM

‪‪−1.20 M‬‬

‪‪−900.00 K‬‬

‪‪−600.00 K‬‬

‪‪−300.00 K‬‬

‪0.00‬

Period

Value

Change

Change %

TTM

‪‪−1.06 M‬‬

+‪‪143.00 K‬‬

+‪11.92‬%

2023

‪‪−1.20 M‬‬

‪‪−338.00 K‬‬

‪−39.21‬%

2022

‪‪−862.00 K‬‬

‪‪−755.00 K‬‬

‪−705.61‬%

2021

‪‪−107.00 K‬‬

—

—

2020

—

—

—

Quarterly data

Q3 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−320.00 K‬‬

‪‪−240.00 K‬‬

‪‪−160.00 K‬‬

‪‪−80.00 K‬‬

‪0.00‬

Period

Value

Change

Change %

Q3 '24

‪‪−245.00 K‬‬

+‪‪4.00 K‬‬

+‪1.61‬%

Q2 '24

‪‪−249.00 K‬‬

+‪‪2.00 K‬‬

+‪0.80‬%

Q1 '24

‪‪−251.00 K‬‬

+‪‪61.00 K‬‬

+‪19.55‬%

Q4 '23

‪‪−312.00 K‬‬

‪‪−6.00 K‬‬

‪−1.96‬%

Q3 '23

‪‪−306.00 K‬‬

‪‪−11.00 K‬‬

‪−3.73‬%

Q2 '23

‪‪−295.00 K‬‬

‪‪−8.00 K‬‬

‪−2.79‬%

Q1 '23

‪‪−287.00 K‬‬

‪‪−42.00 K‬‬

‪−17.14‬%

Q4 '22

‪‪−245.00 K‬‬

‪‪−18.00 K‬‬

‪−7.93‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q3 '20